| 101 |
17990907 | Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities. | 2009 Mar-Apr |
1 |
| 102 |
19028034 | Recent advances in neurobiology of Tuberous Sclerosis Complex. | 2009 Feb |
1 |
| 103 |
19286253 | New insights into the role of the tuberous sclerosis genes in leukemia. | 2009 Jul |
1 |
| 104 |
19297407 | Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment. | 2009 Apr 15 |
2 |
| 105 |
19420259 | Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner. | 2009 May 6 |
1 |
| 106 |
19539245 | Efficacy of combined inhibition of mTOR and ERK/MAPK pathways in treating a tuberous sclerosis complex cell model. | 2009 Jun |
3 |
| 107 |
19694899 | From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis. | 2009 Oct |
1 |
| 108 |
19917366 | Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex. | 2009 Nov |
3 |
| 109 |
18094094 | Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis. | 2008 Jan 1 |
1 |
| 110 |
18350576 | Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. | 2008 Apr |
2 |
| 111 |
18389497 | Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. | 2008 Apr |
1 |
| 112 |
17179073 | Opposite effects of tor1 and tor2 on nitrogen starvation responses in fission yeast. | 2007 Mar |
3 |
| 113 |
17637444 | Tuberous sclerosis complex: advances in diagnosis, genetics, and management. | 2007 Aug |
1 |
| 114 |
17986349 | Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779. | 2007 Nov 6 |
2 |
| 115 |
16412252 | Hypoxia-inducible factor-1alpha polymorphisms and TSC1/2 mutations are complementary in head and neck cancers. | 2006 Jan 16 |
2 |
| 116 |
15578690 | Efficacy of a rapamycin analog (CCI-779) and IFN-gamma in tuberous sclerosis mouse models. | 2005 Mar |
1 |
| 117 |
16244323 | Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways. | 2005 Oct 15 |
1 |
| 118 |
15150095 | Perturbed IFN-gamma-Jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models: synergistic effects of rapamycin-IFN-gamma treatment. | 2004 May 15 |
2 |
| 119 |
15565817 | The tuberous sclerosis complex genes in tumor development. | 2004 |
1 |
| 120 |
12773161 | Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins. | 2003 Jun |
1 |
| 121 |
14500340 | Loss of Tsc1 or Tsc2 induces vascular endothelial growth factor production through mammalian target of rapamycin. | 2003 Sep 1 |
1 |
| 122 |
14607085 | Rheb fills a GAP between TSC and TOR. | 2003 Nov |
1 |
| 123 |
12384518 | Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors. | 2002 Oct 15 |
1 |